Increased risk of group B streptococcal disease in twins

JAMA
|May 22, 1981
PubMed

Insights

Infants from multiple births, like twins and triplets, face a higher risk of invasive group B streptococcal infections. This study examines these cases and proposes a treatment approach for unaffected siblings.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Pediatrics

Background:

  • Infants from multiple births represent a newly identified patient group with heightened susceptibility to invasive infections.
  • Group B Streptococcus (GBS) is a significant pathogen in neonates, causing early- and late-onset disease.

Purpose of the Study:

  • To define the clinical and bacteriological characteristics of invasive GBS infections in infants from multiple births.
  • To explore reasons for increased susceptibility in these infants and their siblings.
  • To propose an empirical treatment strategy for the uninfected sibling of a neonate with invasive GBS infection.

Main Methods:

  • Retrospective review of clinical data and microbiological findings.
  • Analysis of 11 twin sets and 1 triplet set with invasive GBS infection.
  • Clinical observation and case-based analysis.

Main Results:

  • Eleven sets of twins and one set of triplets were identified with invasive GBS infections in one or more infants.
  • The study details the clinical presentations and bacteriological profiles of these infections.
  • Factors contributing to the increased susceptibility in multiple births are discussed.

Conclusions:

  • Infants from multiple births are at increased risk for invasive GBS infections.
  • Understanding the susceptibility factors is crucial for prevention and management.
  • An empirical treatment approach for the uninfected sibling is suggested to mitigate risk.

Related Concept Videos

Probability Laws01:49

Probability Laws

Overview
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...